Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Total Non-Current Liabilities (2023 - 2024)

Mangoceuticals (MGRX) has disclosed Total Non-Current Liabilities for 2 consecutive years, with $12167.0 as the latest value for Q3 2024.

  • Quarterly Total Non-Current Liabilities fell 85.07% to $12167.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $12167.0 through Sep 2024, down 85.07% year-over-year, with the annual reading at $64961.0 for FY2023, N/A changed from the prior year.
  • Total Non-Current Liabilities hit $12167.0 in Q3 2024 for Mangoceuticals, down from $30117.0 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $113267.0 in Q1 2023 to a low of $12167.0 in Q3 2024.